Autologous Bone Marrow Stem Cells for Children With Autism
Spectrum Disorders The purpose of this study is to determine
whether the plasticity of autologous intrathecal hematopoietic
cells would improve the neurologic and the social skills of
pediatric patients with autism spectrum disorders. |Study
Design:||Allocation: Non-Randomized Endpoint Classification:
Safety/Efficacy Study Intervention Model: Crossover Assignment
Masking: Open Label Primary Purpose: Treatment |Official
Title:||Autologous Bone Marrow Stem Cells for Children With
Autism Spectrum Disorders| - IDEA Improvement [ Time Frame: 6
months ] [ Designated as safety issue: Yes ]Improvement in IDEA
evaluation - CARS improvement [ Time Frame: 6 months ] [
Designated as safety issue: Yes ]Improvement in CARS evaluation
|Study Start Date:||November 2012| |Estimated Primary Completion
Date:||November 2013 (Final data collection date for primary
outcome measure)| Experimental: Experimental: Patients Children
who will receive intrathecal autologous stem